BACE1 and early-onset autosomal dominant Alzheimer disease: These results suggested the therapeutic benefit of DC exosomes in Alzheimer’s disease since BACE1 is responsible for the N-terminal cleavage of amyloid precursor protein that produces the aggregate-forming β-amyloid peptide in Alzheimer’s disease pathogenesis (112).